Announcement on Convening Performance Briefing for 2025 and Q1 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening Performance Briefing for 2025 and Q1 2026
Filed with SSE · · 3 pages · Chinese
Release
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited on 6ix
Earlier from Guangzhou Baiyunshan Pharmaceutical
- Announcement on Obtaining Notice of Approval for Drug Supplementary Application by a Subsidiary
- Announcement on Election of Board of Directors at Expiry of Term of Office
- Announcement on Change of Subsidiary's Drug Production License
- Announcement on Resolutions of the 34th Meeting of the 9th Board of Directors
- Announcement on Recognition of Subsidiary as High-tech Enterprise
Later from Guangzhou Baiyunshan Pharmaceutical
- Announcement on Election of Employee Representative Director
- Announcement on Completing Term Change of the Board of Directors and Appointing Senior Management Members
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Branch Receiving Drug Registration Certificate
- "Corporate Value and Return Enhancement" Action Plan 2026
Follow Guangzhou Baiyunshan Pharmaceutical into a list and get an email when it puts out news.
Follow Guangzhou Baiyunshan Pharmaceutical